Skip to content

Clinical trials

Completed Ocular Hypertension trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ocular Hypertension Status: Completed Country / region: United States Clear all

231 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20017
20023
20037
20041
20059
200611
200712
200813
200914
201013
201111
201213
201313
201421
201510
20165
20177
201814
20199
20206
20217
20223
20232
20246
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed231

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allergan41
Alcon Research30
Aerie Pharmaceuticals18
Santen Inc.12
Mati Therapeutics Inc.10
Bausch & Lomb Incorporated8
Qlaris Bio, Inc.6
ForSight Vision5, Inc.5
Ocular Therapeutix, Inc.5
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ocular Hypertension231
Glaucoma, Open-Angle150
Glaucoma117
Hypertension7
Eye Diseases5
Exfoliation Syndrome4
Dry Eye Syndromes2
Low Tension Glaucoma2
Macular Degeneration2
Sturge-Weber Syndrome2

Trials

Showing 1 to 25 of 231. Each trial links to its page on Pharma Observatory.

131 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.